James C. Gilbert

CEO Band Therapeutics
Band Therapeutics, LLC.
Lexington, Massachusetts, United States

Presentation(s):

• PB0352 - Effects of the von Willebrand Factor binding Aptamer Rondaptivon Pegol (BT200) on Embryo-Fetal Development in Rabbits

  Sunday, June 23, 2024
  13:45 – 14:45 ICT